nefazodone has been researched along with Somatoform Disorders in 2 studies
nefazodone: may be useful as an opiate adjunct
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nefazodone is an antidepressant medication which received approval from the Food and Drug Administration for treatment of major depressive disorder in 1994." | 4.80 | The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration. ( Khouzam, HR, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khouzam, HR | 1 |
| Menza, M | 1 |
| Lauritano, M | 1 |
| Allen, L | 1 |
| Warman, M | 1 |
| Ostella, F | 1 |
| Hamer, RM | 1 |
| Escobar, J | 1 |
1 review available for nefazodone and Somatoform Disorders
| Article | Year |
|---|---|
The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration.
Topics: Antidepressive Agents, Second-Generation; Biological Availability; Depressive Disorder; Dose-Respons | 2000 |
1 trial available for nefazodone and Somatoform Disorders
| Article | Year |
|---|---|
Treatment of somatization disorder with nefazodone: a prospective, open-label study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Pilot Proj | 2001 |